A Cost-Effective Assessment for
Celiac Disease and Gluten Sensitivity

 
 
 
 

»  Uses FDA-cleared markers to detect Celiac Disease 

»  Measures both IgA and IgG as opposed to reflexive screening

»  Includes Wheat Allergy IgE analysis

»  Blood spot version available July 2014

»  Low prompt payment price of $99.00

 
 
 
  Follow links below to view sample reports of other suggested Doctor’s Data profiles  
 
 
Want to see the latest research on this topic?
 

Spatola BN1, Kaukinen K, Collin P, Mäki M, Kagnoff MF, Daugherty PS.  Persistence of elevated deamidated gliadin peptide antibodies on a gluten-free diet indicates nonresponsive coeliac disease.  Aliment Pharmacol Ther. 2014 Feb;39(4):407-17. 

Di Simone N et al.,  Potential new mechanisms of placental damage in celiac disease: anti-transglutaminase antibodies impair human endometrial angiogenesis.  Biol Reprod. 2013 Oct 17;89(4):88.

Kappler M, Krauss-Etschmann S, Diehl V, Zeilhofer H, Koletzko S.  Detection of secretory IgA antibodies against gliadin and human tissue transglutaminase in stool to screen for coeliac disease in children: validation study.   BMJ. 2006 Jan 28;332(7535):213-4.

 

IPAD Giveaway
 
Doctor’s Data would like to thank everyone that stopped by our booth at the recent IFM Symposium in San Francisco and registered for the IPAD Mini giveaways.  Congratulations to the winners Dr. Joseph Iaccino and Dr. Jessica Carter!  Thank you again, and we look forward to seeing you at future IFM events!

 

Why Choose Doctor's Data, Inc.?

 

Doctor's Data, Inc. has provided innovative specialty testing to healthcare practitioners around the world from our advanced CLIA licensed clinical laboratory since 1972.

A specialist and pioneer in essential and toxic elemental testing, the laboratory provides a wide array of functional testing to aide in decision making and better patient outcomes. Choose DDI to help you assess and treat heavy metal burden, nutritional deficiencies, gastrointestinal function, cardiovascular risk, liver and metabolic abnormalities, and more.